Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: Activity against staphylococci and enterococci

International Journal of Antimicrobial Agents

Volumn 37, Issue 1, 2011, Pages 39-45

  Putnam, Shannon D ^a,b   Sader, Helio S ^a   Farrell, David J ^a   Biedenbach, Douglas J ^a   Castanheira, Mariana ^a  

^a JMI LABORATORIES   (United States)

^b NONE   (United States)

Author keywords

Enterococci; Fluoroketolide; MLSB; Solithromycin; Staphylococci; Telithromycin

Indexed keywords

CEM 101; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; KETOLIDE; LEVOFLOXACIN; LINEZOLID; SOLITHROMYCIN; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; STRAIN DIFFERENCE; WILD TYPE;

ANTI-BACTERIAL AGENTS; ENTEROCOCCUS; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; TRIAZOLES;

EID: 78650276690     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.08.021     Document Type: Conference Paper

References (25)

1. S.V. Kazakova, J.C. Hageman, M. Matava, A. Srinivasan, L. Phelan, and B. Garfinkel A clone of methicillin-resistant Staphylococcus aureus among professional football players N Engl J Med 352 2005 468 475
2. P.C. Appelbaum The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus Clin Microbiol Infect 12 Suppl. 1 2006 16 23
3. S.K. Shukla Community-associated methicillin-resistant Staphylococcus aureus and its emerging virulence Clin Med Res 3 2005 57 60
4. K. Hiramatsu, H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F.C. Tenover Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility J Antimicrob Chemother 40 1997 135 136
5. F.C. Tenover, L.M. Weigel, P.C. Appelbaum, L.K. McDougal, J. Chaitram, and S. McAllister Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania Antimicrob Agents Chemother 48 2004 275 280 (Pubitemid 38040208)
6. D.J. Farrell, H.S. Sader, M. Castanheira, D.J. Biedenbach, P.R. Rhomberg, and R.N. Jones Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates Int J Antimicrob Agents 35 2010 537 543
7. R.N. Jones Antimicrobial characterization of CEM-101: PAE, bactericidal activity and combinations 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 25-28 October 2008, Washington, DC 2008 ASM Press Washington, DC [Abstract F1-3981]
8. R.N. Jones, D.J. Biedenbach, P.R. Rhomberg, T.R. Fritsche, and H.S. Sader Antimicrobial characterization of CEM-101 activity against 331 respiratory tract pathogens including multidrug-resistant pneumococcal serogroup 19A (MDR-19A) isolates 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 25-28 October 2008, Washington, DC 2008 ASM Press Washington, DC [Abstract F1-3975]
9. R.N. Jones, H.S. Sader, T.R. Fritsche, D.J. Biedenbach, and M. Castanheira Antimicrobial potential application against species causing enteritis/gastroenteritis 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 25-28 October 2008, Washington, DC 2008 ASM Press Washington, DC [Abstract F1-3977]
10. B. Llano-Sotelo, D. Klepacki, and A.S. Mankinb Binding and action of CEM-101, a new macrolide/ketolide in development for treating infections with macrolide-resistant and macrolide-susceptible bacteria 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 25-28 October 2008, Washington, DC 2008 ASM Press Washington, DC [Abstract F-3983]
11. P.M. Roblin, S.A. Kohloff, and M.R. Hammerschlag In vitro activity of CEM101, a new ketolide antibiotic against Chlamydia trachomatis and Chlamydia pneumoniae 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 25-28 October 2008, Washington, DC 2008 ASM Press Washington, DC [Abstract F1-3978]
12. K.B. Waites, D.M. Crabb, and L.B. Duffy Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101 Antimicrob Agents Chemother 53 2009 2139 2141
13. P. McGhee, C. Clark, K.M. Kosowska-Shick, K. Nagai, B. Dewasse, and L. Beachel In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms Antimicrob Agents Chemother 54 2010 230 238
14. M.C. Roberts, J. Sutcliffe, P. Courvalin, L.B. Jensen, J. Rood, and H. Seppala Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants Antimicrob Agents Chemother 43 1999 2823 2830
15. E.C. Kouvela, D.L. Kalpaxis, D.N. Wilson, and G.P. Dinos Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity Antimicrob Agents Chemother 53 2009 1411 1419
16. B. Weisblum Erythromycin resistance by ribosome modification Antimicrob Agents Chemother 39 1995 577 585
17. B. Weisblum Insights into erythromycin action from studies of its activity as inducer of resistance Antimicrob Agents Chemother 39 1995 797 805
18. B. Weisblum Macrolide resistance Drug Resist Updat 1 1998 29 41
19. A.D. Brinker, R.T. Wassel, J. Lyndly, J. Serrano, M. Avigan, and W.M. Lee Telithromycin-associated hepatotoxicity: clinical spectrum and causality assessment of 42 cases Hepatology 49 2009 250 257
20. O. Onur, O. Guneysel, A. Denizbasi, and C. Celikel Acute hepatitis attack after exposure to telithromycin Clin Ther 29 2007 1725 1729
21. G.G. Zhanel, M. Walters, A. Noreddin, L.M. Vercaigne, A. Wierzbowski, and J.M. Embil The ketolides: a critical review Drugs 62 2002 1771 1804
22. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009.
23. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M07-A8. Wayne, PA: CLSI; 2009.
24. F.J. Schmitz, R. Sadurski, A. Kray, M. Boos, R. Geisel, and K. Köhrer Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals J Antimicrob Chemother 45 2000 891 894
25. D.J. Biedenbach, L.M. Deshpande, T.R. Fritsche, H.S. Sader, and R.N. Jones Antimicrobial characterization of CEM-101: activity against enterococci, uncommon Gram-positive pathogens, N. gonorrhoeae and anaerobes 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 25-28 October 2008, Washington, DC 2008 ASM Press Washington, DC [Abstract F1-9376]